BMT Program Now a Member of PIDTC

Under the leadership of Dr. Arun Modi (Hematology/Oncology), the Bone Marrow Transplant (BMT) program is now a part of the Primary Immune Deficiency Treatment Consortium (PIDTC) – an NIH-funded consortium of select children’s hospitals involved in the diagnosis, cutting-edge research, and new clinical trials for Primary Immune deficiency disorders.

This is a great honor and achievement to be included in the PIDTC. “This is a feather in the cap of Dr. Modi and his BMT team”, says Dr. Yatin Vyas, Division Director for Hematology/Oncology.

Leave a Reply

Your email address will not be published. Required fields are marked *